Cyclopharm

Cyclopharm Dividend

The Dividend of Cyclopharm (CYC.AX) as of Oct 19, 2026 is 0.01 AUD. In the previous year, Dividend was 0.01 AUD — a change of 0.00% (lower).

Dividend

0.01AUD

YoY

0.00%

Dividend yield

2.50 %

Last updated:

How much dividend does Cyclopharm 2026 pay?

According to the latest status from October 2026, Cyclopharm paid a total of 0.01 AUD per share in dividends within the last 12 months. With the current Cyclopharm price of 0.40 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Cyclopharm currently offers a dividend yield of about 2.50%. The dividend has grown at 4.4% per year over the past 8 years.

Historical Cyclopharm Dividends

Historical Cyclopharm Dividends
PaydateDividend
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.01AUD
0.00AUD
0.01AUD
0.01AUD
0.01AUD

The Cyclopharm Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2021
0.01 AUD
Jan 1, 2022
0.01 AUD
Jan 1, 2023
0.01 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026 (e)
0.01 AUD
Jan 1, 2027 (e)
0.01 AUD
Jan 1, 2028 (e)
0.01 AUD
The Cyclopharm Dividend history
YEARDividendYoY
est0.01AUD0.00%
est0.01AUD0.00%
est0.01AUD—
0.00AUD—
0.00AUD-100.00%
0.01AUD0.00%
0.01AUD0.00%
0.01AUD0.00%
0.01AUD0.00%
0.01AUD0.00%
0.01AUD+0.45%
0.01AUD-23.49%
0.01AUD+83.80%
0.01AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the Cyclopharm Dividend Safe?

Cyclopharm has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Cyclopharm dividend payout ratio

In 2025, Cyclopharm had a payout ratio of 47.33%. The payout ratio indicates the percentage of the company's profits that Cyclopharm distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-18.53 %
Jan 1, 2022
-14.07 %
Jan 1, 2023
-20.02 %
Jan 1, 2024
47.33 %
Jan 1, 2025
47.33 %
Jan 1, 2026 (e)
60.28 %
Jan 1, 2027 (e)
51.64 %
Jan 1, 2028 (e)
53.08 %

Dividend Details

Understanding Cyclopharm's Dividend Distributions

Cyclopharm’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Cyclopharm's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Cyclopharm's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Cyclopharm’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Cyclopharm Stock analysis

What does Cyclopharm do? Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyclopharm stock

Over the past 12 months, Cyclopharm paid a dividend of 0.01 AUD . This corresponds to a dividend yield of about 2.50 %. For the coming 12 months, Cyclopharm is expected to pay a dividend of 0.01 AUD.

The current dividend yield of Cyclopharm is 2.50 %.

Cyclopharm pays a dividend, distributed in the months of April, September, March.

Cyclopharm paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.01 AUD are expected. This corresponds to a dividend yield of 2.38 %.

Cyclopharm is assigned to the 'Health' sector.

To receive the latest dividend of Cyclopharm from 9/11/2023 amounting to 0.01 AUD, you needed to have the stock in your portfolio before the ex-date on 9/1/2023.

The last dividend was paid out on 9/11/2023.

In the year 2023, Cyclopharm distributed 0.01 AUD as dividends.

The dividends of Cyclopharm are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Cyclopharm